Skip to content
value.today
Teladoc, Inc. logo

Teladoc, Inc.

Formerly TelaDoc, Inc., a Texas corporation, Cyber Medical Services, Inc.

Total raised
$82 M
4 rounds on record
Latest round
$50 M
Sep 2014
First round on record
Nov 2009
Today
Went public
See the company page

Teladoc, Inc. is listed today as Teladoc Health, Inc.: market value, financials and filings are on its company page.

Funding rounds

4 counted as startup funding, 4 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Teladoc, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jul 2020$834 MPrivate placement after listing$250 million to $1 billion

Teladoc, Inc.: Private sale, Jul 2020

Investors in this round

172 investors had bought by the notice of Jul 10, 2020: 172 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 13 investors are named for Teladoc, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$834 M of $834 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Adam C. Vandervoort · Executive Officer
  • Andrew M. Turitz · Executive Officer
  • Christopher F. Caridi · Executive Officer
  • David W. Sides · Executive Officer
  • Jason N. Gorevic · Executive Officer, Director
  • Lewis C. Levy · Executive Officer
  • Mala C. Murthy · Executive Officer
  • Michelle C. Bucaria · Executive Officer
  • Stephanie F. Verstraete · Executive Officer
  • Catherine A. Jacobson · Director
  • David B. Snow · Director
  • David L. Shedlarz · Director
  • Helen H. Darling · Director
  • Kenneth H. Paulus · Director
  • Mark D. Smith · Director
  • Michael M. Goldstein · Director
  • Tom G. Mckinley · Director
  • William H. Frist · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Adam C. Vandervoort, Chief Legal Officer. Source: SEC Form D, newest notice filed Jul 10, 2020. Read the notice at the SEC.

equitySEC
Jul 2017$65 MPrivate placement after listing$50 to $250 million

Teladoc, Inc.: Private sale, Jul 2017

Investors in this round

116 investors had bought by the notice of Jul 25, 2017: 107 accredited, 9 not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 13 investors are named for Teladoc, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$65 M of $65 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Over $100 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Adam C. Vandervoort · Executive Officer
  • Gabriel R. Cappucci · Executive Officer
  • Jason Gorevic · Executive Officer, Director
  • Mark Hirschhorn · Executive Officer
  • Michael King · Executive Officer
  • Arneek G. Multani · Director
  • David B. Snow, Jr. · Director
  • David H. Shedlarz · Director
  • Helen B. Darling · Director
  • Kenneth H. Paulus · Director
  • Michael R. Goldstein · Director
  • Thomas G. Mckinley · Director
  • Thomas H. Mawhinney · Director
  • William H. Frist · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On a merger: “1,855,078 shares of the issuer's common stock are being issued in connection with the acquisition of Best Doctors Holdings, Inc. by the issuer on July 14, 2017.”

Signed by Adam C. Vandervoort, Chief Legal Officer. Source: SEC Form D, newest notice filed Jul 25, 2017. Read the notice at the SEC.

equitySEC
Jul 2016$80 MPrivate placement after listing$50 to $250 million

Teladoc, Inc.: Private sale, Jul 2016

Investors in this round

17 investors had bought by the notice of Jul 12, 2016: 17 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 13 investors are named for Teladoc, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$80 M of $80 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
$25 million to $100 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Adam C. Vandervoort · Executive Officer
  • Gabriel R. Cappucci · Executive Officer
  • Jason Gorevic · Executive Officer, Director
  • Mark Hirschhorn · Executive Officer
  • Michael King · Executive Officer
  • Arneek G. Multani · Director
  • Dana G. Mead, Jr. · Director
  • David B. Snow, Jr. · Director
  • Helen B. Darling · Director
  • James G. Outland · Director
  • Martin R. Felsenthal · Director
  • Michael R. Goldstein · Director
  • Thomas G. Mckinley · Director
  • Thomas H. Mawhinney · Director
  • William H. Frist · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Represents the value of the issuer's common stock issued in connection with the Merger based on an agreed per share price of $11.5012 per share of common stock.”
  • On a merger: “"6,955,796 shares of the issuer's common stock are being issued in connection with the merger (the ""Merger"") of a wholly owned subsidiary of the issuer into HY Holdings, which occurred on July 1, 2016."”

Signed by Adam C. Vandervoort, Chief Legal Officer. Source: SEC Form D, newest notice filed Jul 12, 2016. Read the notice at the SEC.

equitySEC
Sep 2014$50 MNo. 4$50 to $250 million

Teladoc, Inc.: Raise no. 4, Sep 2014

Investors in this round

40 investors had bought by the notice of Sep 19, 2014: 40 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 13 investors are named for Teladoc, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$50 M of $50 M offered
Smallest investment taken
$100,002
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
$25 million to $100 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Daniel B. Trencher · Executive Officer
  • Henry B. DePhillips · Executive Officer
  • Jason Gorevic · Executive Officer, Director
  • Jeff Nadler · Executive Officer
  • Kevin Williamson · Executive Officer
  • Mark B. Hirschhorn · Executive Officer
  • Mike B. King · Executive Officer
  • Thomas B. Seaman · Executive Officer
  • Arneek B. Multani · Director
  • Dana G. Mead, Jr. · Director
  • David B. Snow, Jr. · Director
  • James B. Outland · Director
  • Martin B. Felsenthal · Director
  • Samuel B. Havens · Director
  • Thomas B. McKinley · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mark Hirschhorn, Chief Financial Officer. Source: SEC Form D, newest notice filed Sep 19, 2014. Read the notice at the SEC.

equitySEC
Aug 2013$15 MIssued in a merger or acquisition$10 to $50 million

Teladoc, Inc.: Private sale, Aug 2013

Investors in this round

5 investors had bought by the notice of Sep 11, 2013: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 13 investors are named for Teladoc, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$15 M of $17 M offered; $2 M still to sell
Smallest investment taken
$93,338
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
$5 million to $25 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Dan Trencher · Executive Officer
  • Henry DePhillips · Executive Officer
  • Jason Gorevic · Executive Officer, Director
  • Jeff Nadler · Executive Officer
  • Kevin Williamson · Executive Officer
  • Mark Hirschhorn · Executive Officer
  • Mike King · Executive Officer
  • Paul Squire · Executive Officer
  • Arneek Multani · Director
  • Dana Mead · Director
  • James Outland · Director
  • John Reardon · Director
  • Martin Felsenthal · Director
  • Samuel Havens · Director
  • Thomas McKinley · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On a merger: “The funds raised through this offering were used to finance an acquisition by way of merger.”

Signed by Jason Gorevic, Chief Executive Officer. Source: SEC Form D, newest notice filed Sep 11, 2013. Read the notice at the SEC.

equitySEC
Aug 2011$19 MNo. 3$10 to $50 million

Teladoc, Inc.: Raise no. 3, Aug 2011

Investors in this round

6 investors had bought by the notice of Sep 9, 2011: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 13 investors are named for Teladoc, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$19 M of $19 M offered
Smallest investment taken
$74,670
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
$1 million to $5 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bill Giles · Executive Officer
  • Jason Gorevic · Executive Officer, Director
  • Jeff Nadler · Executive Officer
  • Kevin Williamson · Executive Officer
  • Mike King · Executive Officer
  • Richard Boxer · Executive Officer
  • Arneek Multani · Director
  • Dana Mead · Director · Elected as Director in connection with transaction at issue.
  • James Outland · Director
  • John Reardon · Director
  • Martin Felsenthal · Director
  • Samuel Havens · Director
  • Thomas McKinley · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Bill Giles, Chief Financial Officer. Source: SEC Form D, newest notice filed Sep 9, 2011. Read the notice at the SEC.

equitySEC
Dec 2010$4 MNo. 2$2 to $10 million

Teladoc, Inc.: Raise no. 2, Dec 2010

Investors in this round

2 investors had bought by the notice of Jan 4, 2011: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 13 investors are named for Teladoc, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$4 M of $5 M offered; $1 M still to sell
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • Rule 505: the former limited-offering exemption (withdrawn in 2017)
Meant to last
a year or less
Issuer's revenue
$5 million to $25 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bill Giles · Executive Officer
  • Jason Gorevic · Executive Officer, Director
  • Kevin Williamson · Executive Officer
  • Mike King · Executive Officer
  • Richard Boxer · Executive Officer
  • Arneek Multani · Director
  • James Outland · Director
  • John Reardon · Director
  • Martin Felsenthal · Director
  • Samuel Havens · Director
  • Thomas McKinley · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Bill Giles, Chief Financial Officer. Source: SEC Form D, newest notice filed Jan 4, 2011. Read the notice at the SEC.

equitySEC
Nov 2009$9 MNo. 1$2 to $10 million

Teladoc, Inc.: Raise no. 1, Nov 2009

Investors in this round

10 investors had bought by the notice of Nov 24, 2009: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 13 investors are named for Teladoc, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$9 M of $9 M offered
Smallest investment taken
$25,000
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
$1 million to $5 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Texas

People named in the notice

  • Bill Giles · Executive Officer
  • Jason Gorevic · Executive Officer, Director
  • Kevin Williamson · Executive Officer
  • Richard Boxer · Executive Officer
  • Arneek Multani · Director
  • Bruce Begia · Director · Terminated as director in connection with transaction at issue.
  • Bruce Quinnell · Director · Terminated as director in connection with transaction at issue.
  • Henry Dreifus · Director · Terminated as director in connection with transaction at issue.
  • James Outland · Director
  • John Reardon · Director
  • Martin Felsenthal · Director · Elected as director in connection with transaction at issue.
  • Samuel Havens · Director
  • Thomas McKinley · Director · Elected as director in connection with transaction at issue.

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “"""Total Offering Amount"" set forth above is an estimate."”

Signed by Bill Giles, Chief Financial Officer. Source: SEC Form D, newest notice filed Nov 24, 2009. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • As the listed company Teladoc Health, Inc., its revenue in fiscal 2025 came from these product and service lines: Access Fees $2.09 billion (83%), Other $438.04 million (17%).

    Annual report (SEC XBRL) · Dec 2025

  • Teladoc, Inc. chose not to state its revenue in its newest notice of a funding round (Jul 2020).

    SEC Form D · Jul 2020

  • Revenue range over time, as stated in its notices: revenue between $5 million and $25 million in 2013; revenue between $25 million and $100 million in 2014; revenue between $25 million and $100 million in 2016; revenue of over $100 million in 2017.

    SEC Form D (revenue range) · Jul 2017

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jul 2020

Products and services#

No products or services of Teladoc, Inc. are on record.

Investors#

13 named in official filings. Open an investor to see everything it has backed.

Investors in Teladoc, Inc.
InvestorKindAmountRoundRoleSource
CHP III LPFund or asset managernot statednot statedHeld Series C-1, D, E and F preferred stock, 10% owner (Form 3, 2015)SEC Form 3
CHP III Management, L.L.C.Fund or asset managernot statednot statedHeld Series C-1, D, E and F preferred stock, 10% owner (Form 3, 2015)SEC Form 3
HLM Venture Associates II, LLCVenture capitalnot statednot statedHeld Series C-1, D, E and F preferred stock, 10% owner (Form 3, 2015)SEC Form 3
HLM Venture Partners II, L.P.Venture capitalnot statednot statedHeld Series C-1, D, E and F preferred stock, 10% owner (Form 3, 2015)SEC Form 3
Jason N. GorevicPersonnot statednot statedHeld Series A-1, C-1 and F preferred stock, director (Form 3, 2015)SEC Form 3
KPCB DGF Associates, LLCOthernot statednot statedHeld Series D and F preferred stock, 10% owner (Form 3, 2015)SEC Form 3
KPCB Digital Growth Founders Fund, LLCFund or asset managernot statednot statedHeld Series D and F preferred stock, 10% owner (Form 3, 2015)SEC Form 3
KPCB Digital Growth Fund, LLCFund or asset managernot statednot statedHeld Series D and F preferred stock, 10% owner (Form 3, 2015)SEC Form 3
Mark HirschhornPersonnot statednot statedHeld Series A-1, C-1 and F preferred stock (Form 3, 2015)SEC Form 3
Michael H. KingPersonnot statednot statedHeld Series A-1, C-1 and F preferred stock (Form 3, 2015)SEC Form 3
Trident Capital Fund VI LPFund or asset managernot statednot statedHeld Series B, C-1, D, E and F preferred stock, 10% owner (Form 3, 2015)SEC Form 3
Trident Capital Fund VI Principals Fund LLCFund or asset managernot statednot statedHeld Series B, C-1, D, E and F preferred stock, 10% owner (Form 3, 2015)SEC Form 3
Trident Capital Management-VI, L.L.C.Fund or asset managernot statednot statedHeld Series B, C-1, D, E and F preferred stock, 10% owner (Form 3, 2015)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 40 investors.

Largest shareholders today

Institutions holding Teladoc Health, Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Teladoc, Inc.
NameRoleNamed in
Adam C. VandervoortExecutive officerJul 2020
Andrew M. TuritzExecutive officerJul 2020
Christopher F. CaridiExecutive officerJul 2020
David W. SidesExecutive officerJul 2020
Jason N. GorevicExecutive officerJul 2020
Lewis C. LevyExecutive officerJul 2020
Mala C. MurthyExecutive officerJul 2020
Michelle C. BucariaExecutive officerJul 2020
Stephanie F. VerstraeteExecutive officerJul 2020
Gabriel R. CappucciExecutive officerJul 2017
Jason GorevicExecutive officerJul 2017
Mark HirschhornExecutive officerJul 2017
Michael KingExecutive officerJul 2017
Daniel B. TrencherExecutive officerSep 2014
Henry B. DePhillipsExecutive officerSep 2014
Jeff NadlerExecutive officerSep 2014
Kevin WilliamsonExecutive officerSep 2014
Mark B. HirschhornExecutive officerSep 2014
Mike B. KingExecutive officerSep 2014
Thomas B. SeamanExecutive officerSep 2014
Dan TrencherExecutive officerSep 2013
Henry DePhillipsExecutive officerSep 2013
Mike KingExecutive officerSep 2013
Paul SquireExecutive officerSep 2013
Bill GilesExecutive officerSep 2011
Richard BoxerExecutive officerSep 2011
Catherine A. JacobsonDirectorJul 2020
David B. SnowDirectorJul 2020
David L. ShedlarzDirectorJul 2020
Helen H. DarlingDirectorJul 2020
Jason N. GorevicDirectorJul 2020
Kenneth H. PaulusDirectorJul 2020
Mark D. SmithDirectorJul 2020
Michael M. GoldsteinDirectorJul 2020
Tom G. MckinleyDirectorJul 2020
William H. FristDirectorJul 2020
Arneek G. MultaniDirectorJul 2017
David B. Snow, Jr.DirectorJul 2017
David H. ShedlarzDirectorJul 2017
Helen B. DarlingDirectorJul 2017

About

American healthcare company.

Went public since 2015. Its SEC number is that of a company listed on a stock exchange.